Cerebral autoregulation is preserved in multiple sclerosis patients

Daniel Ferreira1, Pedro Castro2, Gonçalo Videira1

  • 1Department of Clinical Neurosciences and Mental Health, Faculty of Medicine of University of Porto, 4200-319 Porto, Portugal.

Insights

Cerebral autoregulation (CA) appears preserved in multiple sclerosis (MS) patients. However, autonomic dysfunction in MS with brainstem lesions may increase blood pressure, warranting further investigation into its disease impact.

Area of Science:

  • Neurology
  • Vascular Biology
  • Autonomic Neuroscience

Background:

  • Multiple sclerosis (MS) is an inflammatory neurological disease potentially involving vascular dysfunction.
  • Cerebral autoregulation (CA) is crucial for maintaining stable cerebral blood flow.
  • Autonomic dysfunction (AD) is frequently observed in MS patients.

Purpose of the Study:

  • To investigate the integrity of CA in relapsing-remitting MS patients.
  • To explore the relationship between CA, AD, MRI lesion load, and hemodynamic parameters in MS.
  • To assess if CA is compromised in MS and its correlation with disease markers.

Main Methods:

  • Transfer function analysis (TFA) was used to assess CA parameters (coherence, gain, phase) in very low, low, and high-frequency domains.
  • Autonomic function was evaluated using heart rate variability and spontaneous baroreflex sensitivity (BRS).
  • Magnetic resonance imaging (MRI) was used to quantify lesion load, particularly in the brainstem.

Main Results:

  • No significant differences in CA parameters were found between MS patients and healthy controls.
  • MS lesion load did not correlate with any CA parameter.
  • Low-frequency (LF) gain positively correlated with BRS in both groups. Brainstem lesion load was associated with higher systolic blood pressure (SBP) in MS patients.

Conclusions:

  • Cerebral autoregulation (CA) is preserved in the studied cohort of MS patients.
  • Autonomic dysfunction (AD) in MS patients with brainstem lesions may contribute to elevated supine systolic blood pressure (SBP).
  • Further research is needed to determine if this systemic deregulation impacts overall disease burden in MS.